Sign in or create an account to add this stock to your watchlist.
About Blackrock Health Sciences Trust (NYSE:BME)
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Industry, Sector and Symbol
Industry Closed-End Fund - Equity
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions
What is Blackrock Health Sciences Trust's stock symbol?
Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."
How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust declared a monthly dividend on Wednesday, May 2nd. Shareholders of record on Tuesday, May 15th will be paid a dividend of $0.20 per share on Thursday, May 31st. This represents a $2.40 annualized dividend and a yield of 6.58%. The ex-dividend date of this dividend is Monday, May 14th. View Blackrock Health Sciences Trust's Dividend History.
Who are some of Blackrock Health Sciences Trust's key competitors?
Who are Blackrock Health Sciences Trust's key executives?
Blackrock Health Sciences Trust's management team includes the folowing people:
- Mr. John M. Perlowski CPA, Chief Exec. Officer and Pres
- Mr. Neal J. Andrews, Chief Financial Officer
- Mr. Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer
- Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
- Mr. Jay M. Fife, Treasurer
Has Blackrock Health Sciences Trust been receiving favorable news coverage?
Headlines about BME stock have been trending somewhat positive on Monday, according to Accern. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a news impact score of 0.11 on Accern's scale. They also assigned headlines about the company an impact score of 46.00 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
Who are Blackrock Health Sciences Trust's major shareholders?
Blackrock Health Sciences Trust's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Royal Bank of Canada (0.71%), UBS Group AG (0.46%), Wells Fargo & Company MN (0.45%), BB&T Securities LLC (0.17%), 1607 Capital Partners LLC (0.15%) and Arete Wealth Advisors LLC (0.12%). Company insiders that own Blackrock Health Sciences Trust stock include Alexander Tsakumis and Gary Gordon Cope. View Institutional Ownership Trends for Blackrock Health Sciences Trust.
Which institutional investors are selling Blackrock Health Sciences Trust stock?
Which institutional investors are buying Blackrock Health Sciences Trust stock?
BME stock was purchased by a variety of institutional investors in the last quarter, including 1607 Capital Partners LLC, Doliver Capital Advisors LP, Cambridge Investment Research Advisors Inc., Royal Bank of Canada, BB&T Securities LLC and Arete Wealth Advisors LLC. Company insiders that have bought Blackrock Health Sciences Trust stock in the last two years include Alexander Tsakumis and Gary Gordon Cope. View Insider Buying and Selling for Blackrock Health Sciences Trust.
How do I buy shares of Blackrock Health Sciences Trust?
Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Blackrock Health Sciences Trust's stock price today?
One share of BME stock can currently be purchased for approximately $36.46.
How big of a company is Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust has a market capitalization of $328.67 million.
How can I contact Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.
MarketBeat Community Rating for Blackrock Health Sciences Trust (BME)MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
Blackrock Health Sciences Trust (NYSE:BME) Analyst Ratings History
(Data available from 5/28/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Blackrock Health Sciences Trust (NYSE:BME) Dividend Information
Blackrock Health Sciences Trust pays an annual dividend of $2.40 per share, with a dividend yield of 6.58%. BME's next monthly dividend payment will be made on Thursday, May 31.
|Dividend Growth:||10.10% (3 Year Average)|
Blackrock Health Sciences Trust (NYSE:BME) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Blackrock Health Sciences Trust (NYSE BME) Insider Trading and Institutional Ownership History
Blackrock Health Sciences Trust (NYSE BME) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/15/2017||Gary Gordon Cope||Director||Sell||700,000||$0.57||$399,000.00|
|6/6/2017||Gary Gordon Cope||Director||Buy||8,500||$0.64||$5,440.00|
|6/5/2017||Gary Gordon Cope||Director||Buy||11,500||$0.66||$7,590.00|
|5/15/2017||Gary Gordon Cope||Director||Buy||9,000||$0.90||$8,100.00|
|5/2/2017||Gary Gordon Cope||Director||Buy||2,000||$0.98||$1,960.00|
|2/9/2017||Gary Gordon Cope||Director||Buy||400||$1.40||$560.00|
|2/2/2017||Gary Gordon Cope||Director||Sell||200,000||$1.45||$290,000.00|
|11/7/2016||Gary Gordon Cope||Director||Buy||10,000||$0.90||$9,000.00|
|3/28/2016||Gary Gordon Cope||Director||Buy||24,500||$0.17||$4,165.00|
|3/25/2016||Gary Gordon Cope||Director||Buy||1,000||$0.17||$170.00|
|3/24/2016||Gary Gordon Cope||Director||Buy||1,000||$0.17||$170.00|
|3/23/2016||Gary Gordon Cope||Director||Buy||80,500||$0.17||$13,685.00|
|3/22/2016||Gary Gordon Cope||Director||Buy||24,000||$0.17||$4,080.00|
|1/27/2016||Gary Gordon Cope||Director||Buy||3,000||$0.08||$240.00|
|1/26/2016||Gary Gordon Cope||Director||Buy||44,000||$0.0850||$3,740.00|
|1/25/2016||Gary Gordon Cope||Director||Buy||6,000||$0.0850||$510.00|
|1/14/2016||Gary Gordon Cope||Director||Buy||54,500||$0.10||$5,450.00|
|11/19/2015||Gary Gordon Cope||Director||Buy||5,000||$0.1350||$675.00|
|10/28/2015||Gary Gordon Cope||Director||Buy||1,500||$0.10||$150.00|
|10/27/2015||Gary Gordon Cope||Director||Buy||3,000||$0.13||$390.00|
|10/1/2015||Gary Gordon Cope||Director||Buy||15,000||$0.10||$1,500.00|
Blackrock Health Sciences Trust (NYSE BME) News Headlines
Blackrock Health Sciences Trust (NYSE:BME) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Blackrock Health Sciences Trust (NYSE:BME) Income Statement, Balance Sheet and Cash Flow Statement
Blackrock Health Sciences Trust (NYSE BME) Stock Chart for Monday, May, 28, 2018